<?xml version="1.0" encoding="utf-8"?>
<!-- Generator: Adobe Illustrator 16.0.0, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"  viewBox="0 0 1321 785"  xml:space="preserve" >
   <defs>
  <style type="text/css">
   <![CDATA[
   @font-face {
	font-family: 'gothicB';
	src: url('../../fonts/gothicB.eot');
	src: url('../../fonts/gothicB.ttf') format('truetype');
}

   ]]>
 </style>
</defs>
  
<g id="Layer_1">
</g>
<g id="Layer_2">
	<g id="F14">
		<text transform="matrix(0.911 0 0 1 9.4922 741.3135)" fill="#FFFFFF" font-family="'century gothic'" font-size="18.1762">Signorovitch JE, et al. One-year and long-term molecular response to nilotinib and dasatinib for newly diagnosed chronic myeloid leukemia: a matching-adjusted</text>
		<text transform="matrix(0.911 0 0 1 9.4922 763.124)" fill="#FFFFFF" font-family="'century gothic'" font-size="18.1762">indirect comparison. Curr Med Res Opin. 2015;31:315–322</text>
		<text transform="matrix(0.911 0 0 1 914.2344 139.7725)" fill="#FFFFFF" font-family="'century gothic'" font-size="36.3524">MMR (%)</text>
		<rect x="20.454" y="68.449" fill="#E5E5E5" width="636.313" height="105.49"/>
		<rect x="20.454" y="13.093" fill="#4A286E" width="636.313" height="55.358"/>
		<rect x="20.454" y="178.097" fill="#E5E5E5" width="636.313" height="378.13"/>
		<text transform="matrix(0.911 0 0 1 44.207 104.7354)" font-family="'century gothic'" font-size="36.3524">• </text>
		<text transform="matrix(0.911 0 0 1 73.4429 104.7354)" fill="#282828" font-family="'century gothic'" font-size="31.1592">Phase III, multicenter, open-label, </text>
		<text transform="matrix(0.911 0 0 1 44.2061 142.1255)" fill="#282828" font-family="'century gothic'" font-size="31.1592" x="32">    randomised trial</text>
		<text transform="matrix(0.911 0 0 1 44.207 245.7944)" font-family="'century gothic'" font-size="36.3524">• </text>
		<text transform="matrix(0.911 0 0 1 73.4429 245.7944)" fill="#282828" font-family="'century gothic'" font-size="31.1592">846 patients were randomised in a 1:1:1 </text>
		<text transform="matrix(0.911 0 0 1 44.2061 283.1841)" fill="#282828" font-family="'century gothic'" font-size="31.1592" x="32">    ratio stratified by Sokal score to receive</text>
		<text transform="matrix(0.911 0 0 1 105.7871 344.4648)" fill="#282828" font-family="'century gothic'" font-size="28.5626">- Nilotinib 300 mg BID,</text>
		<text transform="matrix(0.911 0 0 1 105.7871 383.938)" fill="#282828" font-family="'century gothic'" font-size="28.5626">- Nilotinib 400 mg BID, or</text>
		<text transform="matrix(0.911 0 0 1 105.7871 423.4111)" fill="#282828" font-family="'century gothic'" font-size="28.5626">- Imatinib 400 mg QD</text>
		<text transform="matrix(0.911 0 0 1 44.207 50.811)" fill="#FFFFFF" font-family="'gothicB'" font-size="36.3524">ENESTnd</text>
		<rect x="662.324" y="68.449" fill="#E5E5E5" width="644.199" height="105.49"/>
		<rect x="662.324" y="13.093" fill="#4A286E" width="644.199" height="55.358"/>
		<rect x="662.324" y="178.097" fill="#E5E5E5" width="644.199" height="378.13"/>
		<text transform="matrix(0.911 0 0 1 685.1074 107.3311)" font-family="'century gothic'" font-size="36.3524">• </text>
		<text transform="matrix(0.911 0 0 1 714.3438 107.3311)" fill="#282828" font-family="'century gothic'" font-size="31.1592">Phase III, multicenter, open-label, </text>
		<text transform="matrix(0.911 0 0 1 685.1055 144.7236)" fill="#282828" font-family="'century gothic'" font-size="31.1592" x="32">    randomised trial</text>
		<text transform="matrix(0.911 0 0 1 685.1074 250.9868)" font-family="'century gothic'" font-size="36.3524">• </text>
		<text transform="matrix(0.911 0 0 1 714.3438 250.9868)" fill="#282828" font-family="'century gothic'" font-size="31.1592">519 patients were randomised in a 1:1 </text>
		<text transform="matrix(0.911 0 0 1 685.1055 288.377)" fill="#282828" font-family="'century gothic'" font-size="31.1592" x="32">    ratio stratified by Hasford score to receive</text>
		<text transform="matrix(0.911 0 0 1 685.1074 53.4063)" fill="#FFFFFF" font-family="'gothicB'" font-size="36.3524">DASISION</text>
		<text transform="matrix(0.911 0 0 1 741.3125 353.1216)" fill="#282828" font-family="'century gothic'" font-size="28.5626">- Dasatinib 100 mg QD or</text>
		<text transform="matrix(0.911 0 0 1 741.3125 392.5952)" fill="#282828" font-family="'century gothic'" font-size="28.5626">- Imatinib 400 mg QD</text>
	</g>
</g>
</svg>
